ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Shu-Lin Yu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5017079221. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2017: 1 paper

Papers 1

Serum lactate dehydrogenase predicts prognosis and correlates with systemic inflammatory response in patients with advanced pancreatic cancer after gemcitabine… Co-author DOI 10.1038/srep45194 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hao Chen · 1 shared paper, 2017 · strength 0.07
- Paper Serum lactate dehydrogenase predicts prognosis and correlates with systemic inflammatory response in patients with adva… DOI 10.1038/srep45194 ↗
Zhen Chen · 1 shared paper, 2017 · strength 0.07
- Paper Serum lactate dehydrogenase predicts prognosis and correlates with systemic inflammatory response in patients with adva… DOI 10.1038/srep45194 ↗
Yawen Geng · 1 shared paper, 2017 · strength 0.07
- Paper Serum lactate dehydrogenase predicts prognosis and correlates with systemic inflammatory response in patients with adva… DOI 10.1038/srep45194 ↗
Peng Wang · 1 shared paper, 2017 · strength 0.07
- Paper Serum lactate dehydrogenase predicts prognosis and correlates with systemic inflammatory response in patients with adva… DOI 10.1038/srep45194 ↗
Qi Qi · 1 shared paper, 2017 · strength 0.07
- Paper Serum lactate dehydrogenase predicts prognosis and correlates with systemic inflammatory response in patients with adva… DOI 10.1038/srep45194 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.